Fair Health Regional Tracker: Telehealth Use Has Decreased Nationally
April 2023 numbers include the privately insured, such as Medicare Advantage.
National telehealth use decreased 5.4% in April 2023, from 5.6% of medical claim lines in March to 5.3% in April, according to FAIR Health's Monthly Telehealth Regional Tracker. The decrease followed an increase in March 2023. In April, telehealth utilization also decreased in all four US census regions—the Midwest (4.7%), Northeast (6.3%), South (6.8%), and West (6.4%). The data represent the privately insured population, including Medicare Advantage and excluding Medicare Fee-for-Service and Medicaid.
Mental health conditions, the top-ranking telehealth diagnosis nationally and in every region, rose from 67.4% of telehealth claim lines nationally in March 2023 to 68.4% in April, marking the fourth straight month of national increases.
The percentage of telehealth claim lines for the second-place diagnosis, acute respiratory diseases and infections, decreased nationally in April, falling from 3.2% in March to 2.7% in April. This was the fourth consecutive national monthly decrease for this diagnosis.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
